Tandem Diabetes Care (TNDM) Gross Margin Growth (3y) (2016 - 2026)
Tandem Diabetes Care (TNDM) Gross Margin Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 264.00 |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 459.00 |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 21.00 |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 8.00 |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -316.00 |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 73.00 |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 90.00 |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -3,577.00 |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 113.00 |
| 10 | Tandem Diabetes Care | 1.56 Bn | 1.10 Bn | 144.78 Mn | 495.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 495.00 |
| Mar 31, 2026 | 638.00 |
| Dec 31, 2025 | 528.00 |
| Sep 30, 2025 | 283.00 |
| Jun 30, 2025 | 139.00 |
| Mar 31, 2025 | -127.00 |
| Dec 31, 2024 | 155.00 |
| Sep 30, 2024 | -277.00 |
| Jun 30, 2024 | -288.00 |
| Mar 31, 2024 | -257.00 |
| Dec 31, 2023 | -647.00 |
| Sep 30, 2023 | -449.00 |
| Jun 30, 2023 | 214.00 |
| Mar 31, 2023 | -238.00 |
| Dec 31, 2022 | -321.00 |
| Sep 30, 2022 | -249.00 |
| Jun 30, 2022 | -261.00 |
| Mar 31, 2022 | 125.00 |
| Dec 31, 2021 | -35.00 |
| Sep 30, 2021 | 675.00 |